These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 12752515

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW, Cho WI, Lee CK, Seo SJ.
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY, Kim ST.
    Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
    To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC.
    Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408
    [Abstract] [Full Text] [Related]

  • 6. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle.
    Kim JH, Shin JH, Kim ST, Kim CY.
    Plast Reconstr Surg; 2007 Feb; 119(2):711-7. PubMed ID: 17230111
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
    Lee JH, Park JH, Lee SK, Han KH, Kim SD, Yoon CS, Park JY, Lee JH, Yang JM, Lee JH.
    J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidental aggravation of venous malformation after botulinum toxin type a injection for reducing benign masseteric hypertrophy.
    Choi JH, Park SW, Chung HY, Choi KY, Chang HW, Kim JH, Son D, Han K, Cho HC, Xu L, Choi TH, Kim S.
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2188-92. PubMed ID: 21134051
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Botulinum Toxin Injections for Masseter Reduction in East Asians.
    Cheng J, Hsu SH, McGee JS.
    Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A.
    Nikolis A, Enright KM, Rudolph C, Cotofana S.
    J Cosmet Dermatol; 2020 Jun; 19(6):1294-1300. PubMed ID: 32338450
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
    Lee SH, Wee SH, Kim HJ, Yeo UC, Lee NH, Lee SW, Cho SB.
    J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570
    [Abstract] [Full Text] [Related]

  • 20. [Chemodenervation with botulinumtoxin in masseteric hypertrophy].
    Mischkowski RA, Siessegger M, Lazar F, Zöller JE.
    Mund Kiefer Gesichtschir; 2005 Mar; 9(2):101-8. PubMed ID: 15711991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.